MEF2C and acute lymphoblastic leukemia: Since MEF2C seems commonly highly expressed in patients with ETP-ALL due to MEF2C or MEF2C-inducing rearrangements (5), MEF2C is also expressed in the subset of patients with ETP-ALL that harbor HOXA-activating rearrangements as a potential collaborative event.